Literature DB >> 21059231

Major surgery in an osteosarcoma patient refusing blood transfusion: case report.

Amreeta Dhanoa1, Vivek A Singh, Rukmanikanthan Shanmugam, Raja Rajendram.   

Abstract

We describe an unusual case of osteosarcoma in a Jehovah's Witness patient who underwent chemotherapy and major surgery without the need for blood transfusion. This 16-year-old girl presented with osteosarcoma of the right proximal tibia requiring proximal tibia resection, followed by endoprosthesis replacement. She was successfully treated with neoadjuvant chemotherapy and surgery with the support of haematinics, granulocyte colony-stimulating factor, recombinant erythropoietin and intraoperative normovolaemic haemodilution. This case illustrates the importance of maintaining effective, open communication and exploring acceptable therapeutic alternative in the management of these patients, whilst still respecting their beliefs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21059231      PMCID: PMC2991319          DOI: 10.1186/1477-7819-8-96

Source DB:  PubMed          Journal:  World J Surg Oncol        ISSN: 1477-7819            Impact factor:   2.754


  14 in total

1.  Mortality and morbidity in patients with very low postoperative Hb levels who decline blood transfusion.

Authors:  Jeffrey L Carson; Helaine Noveck; Jesse A Berlin; Steven A Gould
Journal:  Transfusion       Date:  2002-07       Impact factor: 3.157

Review 2.  Haematological care of the Jehovah's Witness patient.

Authors:  Judith C W Marsh; David H Bevan
Journal:  Br J Haematol       Date:  2002-10       Impact factor: 6.998

3.  Management of the Jehovah's Witness Oncology Patient: Perspective of the Transfusion Service.

Authors: 
Journal:  Cancer Control       Date:  1995-11       Impact factor: 3.302

Review 4.  Jehovah's Witnesses in the emergency department: what are their rights?

Authors:  S Woolley
Journal:  Emerg Med J       Date:  2005-12       Impact factor: 2.740

Review 5.  Interleukin-11: review of molecular, cell biology, and clinical use.

Authors:  X Du; D A Williams
Journal:  Blood       Date:  1997-06-01       Impact factor: 22.113

6.  Hypervolaemic haemodilution in an anaemic Jehovah's Witness.

Authors:  A Trouwborst; R R Hagenouw; J Jeekel; G L Ong
Journal:  Br J Anaesth       Date:  1990-05       Impact factor: 9.166

7.  Reduction in transfusion requirements with early epoetin alfa treatment in pediatric patients with solid tumors: a case-control study.

Authors:  Martina Kronberger; Gustav Fischmeister; Ulrike Poetschger; Helmut Gadner; Andreas Zoubek
Journal:  Pediatr Hematol Oncol       Date:  2002-03       Impact factor: 1.969

8.  Efficacy of recombinant human erythropoietin in the critically ill patient: a randomized, double-blind, placebo-controlled trial.

Authors:  H L Corwin; A Gettinger; R M Rodriguez; R G Pearl; K D Gubler; C Enny; T Colton; M J Corwin
Journal:  Crit Care Med       Date:  1999-11       Impact factor: 7.598

Review 9.  The contemporary approach to the care of Jehovah's witnesses.

Authors:  Duncan B Hughes; Brant W Ullery; Philip S Barie
Journal:  J Trauma       Date:  2008-07

10.  Are transfusions overrated? Surgical outcome of Jehovah's Witnesses.

Authors:  C S Kitchens
Journal:  Am J Med       Date:  1993-02       Impact factor: 4.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.